ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 115 filers reported holding ENZO BIOCHEM INC in Q3 2017. The put-call ratio across all filers is 2.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $62,000 | +100.0% | 30,133 | +147.4% | 0.01% | +66.7% |
| Q4 2020 | $31,000 | +24.0% | 12,182 | +8.8% | 0.00% | 0.0% |
| Q2 2020 | $25,000 | -84.6% | 11,194 | -76.7% | 0.00% | -66.7% |
| Q2 2019 | $162,000 | +194.5% | 48,036 | +262.9% | 0.01% | +200.0% |
| Q3 2018 | $55,000 | -3.5% | 13,237 | +28.3% | 0.00% | 0.0% |
| Q1 2018 | $57,000 | -73.1% | 10,321 | -49.1% | 0.00% | -70.0% |
| Q3 2017 | $212,000 | – | 20,263 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Evermore Global Advisors, LLC | 3,555,233 | $39,250,000 | 9.97% |
| CORRADO ADVISORS, LLC | 326,101 | $3,600,000 | 1.97% |
| KOPP INVESTMENT ADVISORS LLC | 199,132 | $2,198,000 | 1.97% |
| First Light Asset Management, LLC | 403,082 | $4,450,000 | 1.49% |
| Millrace Asset Group, Inc. | 115,878 | $1,279,000 | 1.21% |
| KEMPNER CAPITAL MANAGEMENT INC. | 95,476 | $1,054,000 | 0.69% |
| MARATHON CAPITAL MANAGEMENT | 115,000 | $1,270,000 | 0.60% |
| Campbell & CO Investment Adviser LLC | 33,513 | $370,000 | 0.34% |
| EAM Investors, LLC | 159,930 | $1,766,000 | 0.29% |
| ABNER HERRMAN & BROCK LLC | 100,000 | $1,104,000 | 0.21% |